tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Roy Buchanan, 43 are a BUY (95.56%), 2 are a HOLD (4.44%).
Analyst Roy Buchanan, currently employed at JMP, carries an average stock price target met ratio of 27.08% that have a potential upside of 22.48% achieved within 121 days.
Roy Buchanan’s has documented 91 price targets and ratings displayed on 10 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on ENTA, Enanta Pharmaceuticals at 09-Oct-2024.
Analyst best performing recommendations are on ENTA (ENANTA PHARMACEUTICALS).
The best stock recommendation documented was for ENTA (ENANTA PHARMACEUTICALS) at 11/8/2021. The price target of $77 was fulfilled within 11 days with a profit of $17.24 (18.29%) receiving and performance score of 16.63.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Buy
$16
$13.46 (529.92%)
$16
2 months 1 days ago
(16-Sep-2024)
0/8 (0%)
$12.73 (389.30%)
Sell
$8
$5.46 (214.96%)
$20
1 years 2 months 27 days ago
(21-Aug-2023)
4/4 (100%)
$-0.89 (-10.01%)
32
Hold
$21
$18.46 (726.77%)
$58
1 years 10 months 11 days ago
(06-Jan-2023)
1/2 (50%)
$12.74 (154.24%)
63
Sell
$47
3 years 6 months 23 days ago
(26-Apr-2021)
1/1 (100%)
$-81.95 (-63.55%)
295
Which stock is Roy Buchanan is most bullish on?
Which stock is Roy Buchanan is most reserved on?
What Year was the first public recommendation made by Roy Buchanan?
